Citation: Zhaoyu Wang, Qiang Chen, Haomiao Zhu, Xiaona Yin, Kun Wang, Yonghui Liu, Wei Zhao. Enhancing the immune response and tumor suppression effect of antitumor vaccines adjuvanted with non-nucleotide small molecule STING agonist[J]. Chinese Chemical Letters, ;2021, 32(6): 1888-1892. doi: 10.1016/j.cclet.2021.01.036 shu

Enhancing the immune response and tumor suppression effect of antitumor vaccines adjuvanted with non-nucleotide small molecule STING agonist

State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy and KLMDASR of Tianjin, Nankai University, Tianjin 300353, China

yhliu@nankai.edu.cn

wzhao@nankai.edu.cn

Received Date: 30 November 2020
Revised Date: 18 January 2021
Accepted Date: 19 January 2021
Available Online: 26 January 2021

Figures(8)

Vaccine adjuvants have been widely used to enhance the immunogenicity of the antigens and elicit long-lasting immune response. However, only few vaccine adjuvants have been approved by the FDA for human use so far. Therefore, there is still an urgent need to develop novel adjuvants for the potential applications in clinical trials. Herein, non-nucleotide small molecule STING agonist diABZI was employed to construct glycopeptide antigen based vaccines for the first time. Immunological evaluation indicated diABZI not only enhanced the production of antibodies and T cell immune responses, but also inhibited tumor growth in tumor-bearing mice in glycopeptide-based subunit vaccines. These results indicated that di-ABZI demonstrates a high potential as adjuvant for the development of cancer vaccines.
- MUC1 antigen,
- Glycopeptide,
- Vaccine adjuvant,
- STING,
- Cancer vaccine
1. [1]
  S.A. Rosenberg, J.C. Yang, N.P. Restifo, Nat. Med. 10(2004) 909-915. doi: 10.1038/nm1100
2. [2]
  I. Mellman, G. Coukos, G. Dranoff, Nature 480(2011) 480-489. doi: 10.1038/nature10673
3. [3]
  T.N. Schumacher, R.D. Schreiber, Science 348(2015) 69-74. doi: 10.1126/science.aaa4971
4. [4]
  I. Melero, G. Gaudernack, W. Gerritsen, et al., Nat. Rev. Clin. Oncol. 11(2014) 509-524. doi: 10.1038/nrclinonc.2014.111
5. [5]
  F.O. Nestle, S. Alijagic, M. Gilliet, et al., Nat. Med. 4(1998) 328-332. doi: 10.1038/nm0398-328
6. [6]
  N. Gaidzik, U. Westerlind, H. Kunz, Chem. Soc. Rev. 42(2013) 4421-4442. doi: 10.1039/c3cs35470a
7. [7]
  S.J. Danishefsky, Y.K. Shue, M.N. Chang, et al., Accounts Chem. Res. 48(2015) 643-652. doi: 10.1021/ar5004187
8. [8]
  L. Zeng, Z. Liao, W. Li, et al., Chin. Chem. Lett. 31(2020) 1162-1164. doi: 10.1016/j.cclet.2019.10.015
9. [9]
  J. Zhao, G. Hu, Y. Huang, et al., Chin. Chem. Lett. 32(2021) 1331-1340. doi: 10.1016/j.cclet.2020.10.013
10. [10]
  Z. Zhou, H. Lin, C. Li, et al., Chin. Chem. Lett. 29(2018) 19-26. doi: 10.1016/j.cclet.2017.09.047
11. [11]
  F. Liao, H. Wang, Y. Dao, et al., Chin. Chem. Lett. 32(2021) 1577-1581.
12. [12]
  N. Petrovsky, J.C. Aguilar, Immunol. Cell Biol. 82(2004) 488-496. doi: 10.1111/j.0818-9641.2004.01272.x
13. [13]
  J.C. Aguilar, E.G. Rodriguez, Vaccine 25(2007) 3752-3762. doi: 10.1016/j.vaccine.2007.01.111
14. [14]
  F.C. Zhu, F.Y. Meng, J.X. Li, et al., Lancet 381(2013) 2024-2032. doi: 10.1016/S0140-6736(13)61049-1
15. [15]
  G.N. Barber, Nat. Rev. Immunol. 15(2015) 760-770. doi: 10.1038/nri3921
16. [16]
  X. Zhou, Z. Jiang, Sci. China-Life Sci. 60(2017) 563-574. doi: 10.1007/s11427-016-9066-0
17. [17]
  D.L. Burdette, K.M. Monroe, K. Sotelo-Troha, et al., Nature 478(2011) 515-U111. doi: 10.1038/nature10429
18. [18]
  J.J. Woodward, A.T. Iavarone, D.A. Portnoy, Science 328(2010) 1703-1705. doi: 10.1126/science.1189801
19. [19]
  T. Ebensen, R. Libanova, K. Schulze, et al., Vaccine 29(2011) 5210-5220. doi: 10.1016/j.vaccine.2011.05.026
20. [20]
  E. Van Dis, K.M. Sogi, C.S. Rae, et al., Cell Rep. 23(2018) 1435-1447. doi: 10.1016/j.celrep.2018.04.003
21. [21]
  D. Chandra, W. Quispe-Tintaya, A. Jahangir, et al., Cancer Immunol. Res. 2(2014) 901-910. doi: 10.1158/2326-6066.CIR-13-0123
22. [22]
  R.D. Junkins, M.D. Gallovic, B.M. Johnson, et al., J. Control. Release 270(2018) 1-13. doi: 10.1016/j.jconrel.2017.11.030
23. [23]
  Z. Wang, E. Celis, Cancer Immunol. Immunother. 64(2015) 1057-1066. doi: 10.1007/s00262-015-1713-5
24. [24]
  A. Landi, J. Law, D. Hockman, et al., Vaccine 35(2017) 6949-6956. doi: 10.1016/j.vaccine.2017.10.072
25. [25]
  J.J. Wu, W.H. Li, P.G. Chen, et al., Chem. Commun. 54(2018) 9655-9658. doi: 10.1039/C8CC04860F
26. [26]
  A. Sanchez Alberti, A.E. Bivona, N. Cerny, et al., NPJ Vacc. 2(2017) 9. doi: 10.1038/s41541-017-0010-z
27. [27]
  A. Li, M. Yi, S. Qin, et al., J. Hematol. Oncol. 12(2019) 35. doi: 10.1186/s13045-019-0721-x
28. [28]
  J.M. Ramanjulu, G.S. Pesiridis, J. Yang, et al., Nature 564(2018) 439-443. doi: 10.1038/s41586-018-0705-y
29. [29]
  J. Volckmar, L. Knop, S. Stegemann-Koniszewski, et al., Vaccine 37(2019) 4963-4974. doi: 10.1016/j.vaccine.2019.07.019
30. [30]
  G. Berger, M. Marloye, S.E. Lawler, T. Trends Mol, Med. 25(2019) 412-427.
31. [31]
  P. Mukherjee, C.S. Madsen, A.R. Ginardi, et al., J. Immunother. 26(2003) 47-62. doi: 10.1097/00002371-200301000-00006
32. [32]
  R. Singh, D. Bandyopadhyay, Cancer Biol. Ther. 6(2014) 481-486.
33. [33]
  S. Ingale, M.A. Wolfert, J. Gaekwad, et al., Nat. Chem. Biol. 3(2007) 663-667. doi: 10.1038/nchembio.2007.25
34. [34]
  J. Taylor-Papadimitriou, J. Burchell, D.W. Miles, et al., BBA-Mol Basis Dis. 1455(1999) 301-313. doi: 10.1016/S0925-4439(99)00055-1
35. [35]
  L. Nuhn, S. Hartmann, B. Palitzsch, et al., Angew. Chem. Int. Ed. 52(2013) 10652-10656. doi: 10.1002/anie.201304212
36. [36]
  H. Cai, Z.Y. Sun, Z.H. Huang, et al., Chem. Eur. J. 19(2013) 1962-1970. doi: 10.1002/chem.201203709
37. [37]
  M. Glaffig, B. Palitzsch, S. Hartmann, et al., Chem. Eur. J. 20(2014) 4232-4236. doi: 10.1002/chem.201400256
38. [38]
  N. Yanase, H. Toyota, K. Hata, et al., Vaccine 32(2014) 5918-5924. doi: 10.1016/j.vaccine.2014.08.059
1. [1]
  Yuxin Tian , Mengjun Li , Yang Yang , Chunhui Li , Yun Peng , Haiyin Yang , Mengyuan Zhao , Pengfei Wu , Shaobo Ruan , Yuanyu Huang , Chenguang Shen , Minghui Yang . An MPXV mRNA-LNP vaccine candidate elicits protective immune responses against monkeypox virus. Chinese Chemical Letters, 2024, 35(8): 109270-. doi: 10.1016/j.cclet.2023.109270
2. [2]
  Junjie Wang , Yan Wang , Zhengdong Li , Changqiang Xie , Musammir Khan , Xingzhou Peng , Fabiao Yu . Triphenylamine-AIEgens photoactive materials for cancer theranostics. Chinese Chemical Letters, 2024, 35(6): 108934-. doi: 10.1016/j.cclet.2023.108934
3. [3]
  Huijie An , Chen Yang , Zhihui Jiang , Junjie Yuan , Zhongming Qiu , Longhao Chen , Xin Chen , Mutu Huang , Linlang Huang , Hongju Lin , Biao Cheng , Hongjiang Liu , Zhiqiang Yu . Luminescence-activated Pt(Ⅳ) prodrug for in situ triggerable cancer therapy. Chinese Chemical Letters, 2024, 35(7): 109134-. doi: 10.1016/j.cclet.2023.109134
4. [4]
  Mengjuan Sun , Muye Zhou , Yifang Xiao , Hailei Tang , Jinhua Chen , Ruitao Zhang , Chunjiayu Li , Qi Ya , Qian Chen , Jiasheng Tu , Qiyue Wang , Chunmeng Sun . Reversibly size-switchable polyion complex micelles for antiangiogenic cancer therapy. Chinese Chemical Letters, 2024, 35(7): 109110-. doi: 10.1016/j.cclet.2023.109110
5. [5]
  Haijing Cui , Weihao Zhu , Chuning Yue , Ming Yang , Wenzhi Ren , Aiguo Wu . Recent progress of ultrasound-responsive titanium dioxide sonosensitizers in cancer treatment. Chinese Chemical Letters, 2024, 35(10): 109727-. doi: 10.1016/j.cclet.2024.109727
6. [6]
  Xiaofang Luo , Ye Wu , Xiaokun Zhang , Min Tang , Feiye Ju , Zuodong Qin , Gregory J Duns , Wei-Dong Zhang , Jiang-Jiang Qin , Xin Luan . Peptide-based strategies for overcoming multidrug-resistance in cancer therapy. Chinese Chemical Letters, 2025, 36(1): 109724-. doi: 10.1016/j.cclet.2024.109724
7. [7]
  Yiran Tao , Chunlei Dai , Zhaoxiang Xie , Xinru You , Kaiwen Li , Jun Wu , Hai Huang . Redox responsive polymeric nanoparticles enhance the efficacy of cyclin dependent kinase 7 inhibitor for enhanced treatment of prostate cancer. Chinese Chemical Letters, 2024, 35(8): 109170-. doi: 10.1016/j.cclet.2023.109170
8. [8]
  Huijiao Fu , Peiqin Liang , Qianwen Chen , Yan Wang , Guang Li , Xuzi Cai , Shengtao Wang , Kun Chen , Shengying Shi , Zhiqiang Yu , Xuefeng Wang . COX-2 blocking therapy in cisplatin chemosensitization of ovarian cancer: An allicin-based nanomedicine approach. Chinese Chemical Letters, 2024, 35(8): 109241-. doi: 10.1016/j.cclet.2023.109241
9. [9]
  Yang Liu , Yan Liu , Kaiyin Yang , Zhiruo Zhang , Wenbo Zhang , Bingyou Yang , Hua Li , Lixia Chen . A selective HK2 degrader suppresses SW480 cancer cell growth by degrading HK2. Chinese Chemical Letters, 2024, 35(8): 109264-. doi: 10.1016/j.cclet.2023.109264
10. [10]
  Xiangqian Cao , Chenkai Yang , Xiaodong Zhu , Mengxin Zhao , Yilin Yan , Zhengnan Huang , Jinming Cai , Jingming Zhuang , Shengzhou Li , Wei Li , Bing Shen . Synergistic enhancement of chemotherapy for bladder cancer by photothermal dual-sensitive nanosystem with gold nanoparticles and PNIPAM. Chinese Chemical Letters, 2024, 35(8): 109199-. doi: 10.1016/j.cclet.2023.109199
11. [11]
  Qiang Li , Jiangbo Fan , Hongkai Mu , Lin Chen , Yongzhen Yang , Shiping Yu . Nucleus-targeting orange-emissive carbon dots delivery adriamycin for enhanced anti-liver cancer therapy. Chinese Chemical Letters, 2024, 35(6): 108947-. doi: 10.1016/j.cclet.2023.108947
12. [12]
  Yihan Zhou , Duo Gao , Yaying Wang , Li Liang , Qingyu Zhang , Wenwen Han , Jie Wang , Chunliu Zhu , Xinxin Zhang , Yong Gan . Worm-like micelles facilitate the intestinal mucus diffusion and drug accumulation for enhancing colorectal cancer therapy. Chinese Chemical Letters, 2024, 35(6): 108967-. doi: 10.1016/j.cclet.2023.108967
13. [13]
  Boran Cheng , Lei Cao , Chen Li , Fang-Yi Huo , Qian-Fang Meng , Ganglin Tong , Xuan Wu , Lin-Lin Bu , Lang Rao , Shubin Wang . Fluorine-doped carbon quantum dots with deep-red emission for hypochlorite determination and cancer cell imaging. Chinese Chemical Letters, 2024, 35(6): 108969-. doi: 10.1016/j.cclet.2023.108969
14. [14]
  Yuanyi Zhou , Ke Ma , Jinfeng Liu , Zirun Zheng , Bo Hu , Yu Meng , Zhizhong Li , Mingshan Zhu . Is reactive oxygen species the only way for cancer inhibition over single atom nanomedicine? Autophagy regulation also works. Chinese Chemical Letters, 2024, 35(6): 109056-. doi: 10.1016/j.cclet.2023.109056
15. [15]
  Jing Chen , Peisi Xie , Pengfei Wu , Yu He , Zian Lin , Zongwei Cai . MALDI coupled with laser-postionization and trapped ion mobility spectrometry contribute to the enhanced detection of lipids in cancer cell spheroids. Chinese Chemical Letters, 2024, 35(4): 108895-. doi: 10.1016/j.cclet.2023.108895
16. [16]
  Ling-Ling Wu , Xiangchuan Meng , Qingyang Zhang , Xiaowan Han , Feiya Yang , Qinghua Wang , Hai-Yu Hu , Nianzeng Xing . Heavy-atom engineered hypoxia-responsive probes for precisive photoacoustic imaging and cancer therapy. Chinese Chemical Letters, 2024, 35(4): 108663-. doi: 10.1016/j.cclet.2023.108663
17. [17]
  Lin Li , Bingjun Sun , Jin Sun , Lin Chen , Zhonggui He . Binary prodrug nanoassemblies combining chemotherapy and ferroptosis activation for efficient triple-negative breast cancer therapy. Chinese Chemical Letters, 2024, 35(10): 109538-. doi: 10.1016/j.cclet.2024.109538
18. [18]
  Yuanzheng Wang , Chen Zhang , Shuyan Han , Xiaoli Kong , Changyun Quan , Jun Wu , Wei Zhang . Cancer cell membrane camouflaged biomimetic gelatin-based nanogel for tumor inhibition. Chinese Chemical Letters, 2024, 35(11): 109578-. doi: 10.1016/j.cclet.2024.109578
19. [19]
  Huamei Zhang , Jingjing Liu , Mingyue Li , Shida Ma , Xucong Zhou , Aixia Meng , Weina Han , Jin Zhou . Imaging polarity changes in pneumonia and lung cancer using a lipid droplet-targeted near-infrared fluorescent probe. Chinese Chemical Letters, 2024, 35(12): 110020-. doi: 10.1016/j.cclet.2024.110020
20. [20]
  Zhi Li , Shuya Pan , Yuan Tian , Shaowei Liu , Weifeng Wei , Jinlin Wang , Tianfeng Chen , Ling Wang . Selenium nanoparticles enhance the chemotherapeutic efficacy of pemetrexed against non-small cell lung cancer. Chinese Chemical Letters, 2024, 35(12): 110018-. doi: 10.1016/j.cclet.2024.110018

Get Citation

PDF

XML

Metrics

PDF Downloads(12)
Abstract views(781)
HTML views(167)

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142